Ingredient or product comparison
The Molecular Architecture: Peptides vs Retinoids
GHK-Cu is a naturally occurring tripeptide. Three amino acids (glycine, histidine, lysine) bound to a copper ion (Cu²⁺). It was first isolated from human plasma in 1973 by Dr. Loren Pickart, who identified it as a growth factor with tissue-remodeling propertie
This source-based comparison does not add ratings or recommend a winner.
- GHK-Cu is a naturally occurring tripeptide. Three amino acids (glycine, histidine, lysine) bound to a copper ion (Cu²⁺). It was first isolated from human plasma in 1973 by Dr. Loren Pickart, who identified it as a growth factor with tissue-remodeling properties. The copper chelation is what drives activity: when GHK-Cu binds to cell surface receptors, the copper ion is released intracellularly and acts as a cofactor for lysyl oxidase, the enzyme responsible for cross-linking collagen and elastin fibers. Without that copper delivery, the structural integrity of newly synthesized collagen is compromised.
- Retinol belongs to the retinoid family. Derivatives of vitamin A. It's fat-soluble and exists in multiple isomeric forms (all-trans, 13-cis, 9-cis). Once applied topically, retinol undergoes two oxidation steps: first to retinaldehyde via retinol dehydrogenase, then to all-trans retinoic acid (ATRA) via retinaldehyde dehydrogenase. Only ATRA has biological activity at the nuclear level. It binds to retinoic acid receptors (RARα, RARβ, RARγ) and retinoid X receptors (RXRα, RXRβ, RXRγ), which form heterodimers and bind to retinoic acid response elements (RAREs) in DNA promoter regions. This triggers transcription of genes coding for collagen, elastin, filaggrin, and matrix metalloproteinase inhibitors.
- The molecular weight matters clinically: GHK-Cu is 340 Da, allowing transdermal penetration when formulated correctly. Retinol is 286 Da. Also permeable, but its activity depends entirely on enzymatic conversion rates post-penetration. Our experience shows that GHK-Cu formulations at 1–3% concentration deliver measurable elasticity improvements within four weeks, while retinol formulations require 12–16 weeks at 0.5–1.0% to reach comparable endpoints.